Aflatoxin B1-Induced COX-2 Expression Promotes Mitophagy and Contributes to Lipid Accumulation in Hepatocytes In Vitro and In Vivo.

International Journal of Toxicology
Xin-Lu RenYiteng Meng

Abstract

Aflatoxin B1 (AFB1) is hepatotoxic. Numerous studies have shown that mitochondria play an essential role in AFB1-induced steatosis. However, the mechanisms of AFB1-induced steatosis via mitochondria are still obscure. The present study aimed to confirm that AFB1 causes hepatocyte steatosis regulated by cyclooxygenase-2 (COX-2)-induced mitophagy, both in vivo and in vitro. Adult male C57BL/6 mice were randomly divided into control group with the same volume of peanut oil and exposure group administered 0.6 mg/kg AFB1 once in 2 days for 1 month. HepG2 and Cas9-PTGS2 cells were treated with 5 μM AFB1 for 48 hours. Then, various indicators were evaluated. Aflatoxin B1 causes liver injury and steatosis with increased alanine aminotransferase, aspartate aminotransferase, total cholesterol, total triglyceride levels in vivo and in vitro, and elevated lipid droplets in HepG2 cells. Cyclooxygenase-2 and mitophagy pathway were induced by AFB1 in both liver tissues and cultured HepG2 cells. Further studies have shown that knockout of COX-2 with the CRISPR/Cas9 system inhibited the AFB1-induced mitophagy and steatosis in HepG2 cells. Also, the inhibition of PTEN-induced putative kinase with RNA interference attenuated the AFB1-induced stea...Continue Reading

References

Dec 22, 2000·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C C BartonR A Roth
Apr 15, 2006·International Journal of Medical Sciences·Eugene J Yoon, Ke-Qin Hu
Jul 25, 2006·Current Biology : CB·Heidi M McBrideSylwia Wasiak
Oct 1, 2010·Anti-cancer Agents in Medicinal Chemistry·Axel H Schönthal
Oct 1, 2010·Toxicological Sciences : an Official Journal of the Society of Toxicology·Thomas W KenslerJohn D Groopman
Aug 26, 2011·The Journal of Clinical Investigation·Kye-Young KimMichael N Sack
Jun 22, 2013·Autophagy·Jianhui ZhuCharleen T Chu
Mar 29, 2014·World Journal of Hepatology·Maria CoppolaFernando Goglia
Jul 31, 2014·Nature Methods·Neville E SanjanaFeng Zhang
Jul 28, 2016·The FEBS Journal·Christina PloumiNektarios Tavernarakis
Sep 21, 2016·Proceedings of the National Academy of Sciences of the United States of America·Deborah NaonLuca Scorrano
Feb 1, 2017·The Journal of Cell Biology·Melissa VosPatrik Verstreken
Jun 15, 2017·World Journal of Gastroenterology : WJG·Paloma Martín-SanzLisardo Boscá
Sep 30, 2017·Toxicology Reports·Oluwakemi Anuoluwapo RotimiFrancis Adedayo Faduyile
Oct 11, 2017·Journal of Agricultural and Food Chemistry·Li YuanChunxia Gao
Mar 14, 2018·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Yu-Ju ChuChien-Jen Chen
May 1, 2019·American Journal of Physiology. Endocrinology and Metabolism·Colin S McCoinJohn P Thyfault
Jul 10, 2019·Journal of Cellular and Molecular Medicine·Yuan-Yuan ChenZhong-Ning Lin
Feb 25, 2020·Clinica Chimica Acta; International Journal of Clinical Chemistry·Anbo GaoLinxi Chen

❮ Previous
Next ❯

Citations

Jan 29, 2021·Frontiers in Pharmacology·Zhenglai HuaYuanyan Liu

❮ Previous
Next ❯

Methods Mentioned

BETA
electrophoresis

Software Mentioned

SPSS
ImageJ

Related Concepts

Related Feeds

CRISPR for Genome Editing

Genome editing technologies enable the editing of genes to create or correct mutations. Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). Here is the latest research on the use of CRISPR-Cas system in gene editing.

CRISPR (general)

Clustered regularly interspaced short palindromic repeats (CRISPR) are DNA sequences in the genome that are recognized and cleaved by CRISPR-associated proteins (Cas). CRISPR-Cas system enables the editing of genes to create or correct mutations. Discover the latest research on CRISPR here.